The presence of moieties denoting viral infection is crucial to mount powerful cytotoxic T-cell immune responses acting through innate receptors such as Toll-like receptor 3 (TLR3). For cancer immunotherapy, several safe analogues of viral double-stranded RNA (dsRNA) are under clinical development following compelling evidence for efficacy in mouse models.
Journal article
Clinical cancer research : an official journal of the American Association for Cancer Research
06/2024
Clinica Universidad de Navarra, CIBERONC, Pamplona, Navarra, Spain.